Cooperative Agreement W81XWH1820070

This Project Grant awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $2,218,222.00 to conduct a randomized clinical trial evaluating the efficacy of brain games and transcranial electrical stimulation in improving cognitive and functional outcomes for active duty service members and veterans with mild traumatic brain injury. The key products/services to be delivered include a four-arm Phase 2 clinical trial...

The Department of Defense's Defense Health Agency awarded a 4-year, $4,778,800 project grant to the University of Virginia (UVA) to conduct the "REACH Intervention for Caregivers of Veterans and Service Members with TBI: Efficacy and Implementation Planning Across the VA Polytrauma System of Care." This grant, funded under the Military Medical Research and Development (CFDA 12.420) program, aims to develop and evaluate the efficacy of the REACH caregiver support intervention for...

This $2.9 million Defense Health Agency project grant funds research on suicide prevention among military personnel and veterans. The grant supports a multi-site randomized clinical trial through September 2026 to evaluate the efficacy of Written Exposure Therapy for Suicide Prevention compared to treatment as usual. Researchers at Boston University and partner institutions University of Colorado Denver and University of Texas Health Science Center San Antonio aim to reduce suicidal thoughts and...

The Defense Health Agency awarded a $1.5 million Project Grant to the Western Institute For Veterans Research to support the POSITIONED (PRECISION, STANDARDIZATION AND ORGANIZATIONAL READINESS IN TBI CARE) program. This funding will support the Military Medical Research and Development program's goal of transforming health care for Service Members and the public through innovative medical research solutions for the battlefield. Specifically, the POSITIONED program will conduct research from...

This Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,565,719 in funding to the University of Pittsburgh to conduct a targeted, randomized, controlled trial on Acceptance and Commitment Therapy integrated with Vestibular Rehabilitation (ACTIVE) for the treatment of mild traumatic brain injury (mTBI). The project has a performance period from September 30, 2023 to September 29, 2027. The University...

This Project Grant award, valued at $1,322,705.00 and awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at Craig Hospital to develop and evaluate a fatigue intervention program for adults with traumatic brain injury (TBI). The award will fund a multi-year research initiative to adapt and test the feasibility of an evidence-based fatigue management intervention for TBI patients, with the goal of improving functional...

This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...

The Department of the Army Medical Command awarded a $5.95 million cooperative agreement to The Johns Hopkins University on September 30, 2022 under the Military Medical Research and Development program (CFDA 12.420). The four-year award will fund a randomized controlled trial to evaluate cognitive-behavioral therapy versus mindfulness-based treatment for insomnia and post-traumatic stress symptoms related to traumatic brain injury. Sub-awards were provided to The Henry M. Jackson Foundation For...

This $608,353 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a longitudinal study by Craig Hospital's Research Department on resilience-related factors influencing psychosocial growth after traumatic brain injury. The study, titled "THRIVING AFTER TBI: A LONGITUDINAL INVESTIGATION OF RESILIENCE-RELATED FACTORS FOR PSYCHOSOCIAL GROWTH AFTER TRAUMATIC BRAIN INJURY," will be conducted over a 3-year...

This federal Project Grant award of $2,580,566, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized clinical trial to evaluate different approaches to rehabilitation for concussion. The award recipient, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will conduct the "SYMPTOM-TARGETED APPROACH TO REHABILITATION FOR CONCUSSION (STAR-C)" study, which will...